1Proesmans W,Wambeke IV,Dyck MV. Long-term therapy with enalapril in patients with nephrotic-range proteinuria. Pedlatr Nephrol, 1996, 10:587 - 589.
2Adler L,Mathew R,Futterweit S,et al. Angiotensin converting enzyme inhibitor therapy in children with Alport syndrome: effect on urinary albumin, TGF-beta, and nitrite excretion. BMC Nephrol, 2002,3: 2.
3Cohen EP,Lemann J Jr. In herediary nephritis angiotensin-converting enzyme inhibition decreases proteinuria and may slow the rate of progression. Am J Kidney Dis, 1996,27:199 - 203.
4Proesmans W, Van Dyck M. Enalapril in children with Alport syndrome. Pediatr Nephrol, 2004, 19:271 - 275.
5Grodecki KM, Gains MJ, Baumal R.Treatment of X-linked hereditary nephritis in Samoyed dogs with angiotensin converting enzyme(ACE) inhibitor. J Comp Pathol, 1997, 117:209 - 225.
6Gross O, Beirowski B, Koepke ML, et al, Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COIAA3-knockout mice with Alport syndrome,Kidney Int, 2003,63:438-446.
7Callis L, Vila A,Carrera M,et al. Long term effects of cyclosporine A in Alport's syndrome. Kidney Int, 1999, 55:1051-1056.
8Charbit M, Dechaux M, Gagnadoux MF, et al. Cyclosporine A therapy in Alport syndrome. Pediatr Nephrol, 2004,19(9): C64.
9Chen D,Jefferson B,Harvey SJ,et al. Cyclosporine A slows the progressive renal disease of Alport syndrome(X-linked hereditary nephritis): results from a canine model.J Am Soc Nephrol,2003, 14:690-698.
10Milliner DS,Pierides AM,Holley KE. Renal transplantation in Alport's syndrome: anti-glomerular basement membrane glomerulonephritis in the allograft. Mayo Clin Proc, 1982, 57: 35-43.
